Esther Welkowsky
Chief Tech/Sci/R&D Officer at ELICIO THERAPEUTICS, INC.
Profile
Esther Welkowsky is currently the Vice President-Clinical Development at Elicio Therapeutics, Inc. (United States) and the Senior Vice President-Clinical Development at Elicio Therapeutics, Inc. She previously worked as the Executive Director-Clinical Operations at Allogene Therapeutics, Inc. from 2018 to 2020.
Prior to that, she was the Head-Clinical Operations at Atara Biotherapeutics, Inc. Ms. Welkowsky completed her undergraduate degree at the University of California, Santa Barbara.
Esther Welkowsky active positions
| Companies | Position | Start |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2020-03-31 |
Former positions of Esther Welkowsky
| Companies | Position | End |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-01-31 |
| ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Esther Welkowsky
| University of California, Santa Barbara | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Esther Welkowsky
